Drori Rachel 4

What Happened

• Rachel Drori, a director of Lifeway Foods, received a grant of 2,038 restricted stock units (RSUs) on July 1, 2026. The filing lists the transaction as an award/acquisition (code A) and the award is a derivative grant (no purchase price or immediate cash value reported).
• The RSUs do not represent immediate shares; each RSU is a contingent right to one share of common stock and will convert to shares only if and when the units vest.

Key Details

• Transaction date: 2026-07-01; Form 4 filed: 2026-07-02 (timely filing).
• Award: 2,038 RSUs; price: N/A (derivative grant — no cash paid).
• Shares owned after transaction: not specified in the filing.
• Footnotes: F1 — each RSU equals the contingent right to one share; F2 — some RSUs vest on December 30, 2026 contingent on continued service; F3 — some RSUs vest on July 1, 2027 contingent on continued service.
• No 10b5-1 plan, tax-withholding sale, or exercise was reported.

Context

• RSU grants to directors are typically compensation for service and are contingent on continued board service until listed vesting dates; they are not the same as an open-market purchase and don’t reflect an immediate cash investment by the insider.
• Because these are unvested derivative awards, they should be viewed as compensation design rather than a direct buy or sell signal.